Lipophilicity, polarity, and hydrophobicity

Comprehensive Medicinal Chemistry II

Volumn 5, Issue , 2006, Pages 425-452

  Caron, G ^a   Ermondi, G ^a   Scherrer, R A ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b BIOpK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77449143179     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (153)

1. Van de Waterbeemd, H.; Smith, D. A.; Beaumont, K.; Walker, D. K. J. Med. Chem. 2001, 44, 1313-1333.
2. Van de Waterbeemd, H.; Smith, D. A.; Jones, B. C. J. Comput.-AidedMol. Design 2001, 15, 273-286.
3. Lombardo, F; Obach, R.; Shalaeva, M. Y; Gao, F J. Med. Chem. 2002, 45, 2867-2876.
4. Lipinski, C. A.; Lombardo, F; Dominy, B. W; Feeney, P J. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
5. Wenlock, M. C.; Austin, R. P.; Barton, P; Davis, A. M.; Leeson, P D. J. Med. Chem. 2003, 46, 1250-1256.
6. Vieth, M.; Siegel, M. G.; Higgs, R. E.; Watson, I. A.; Robertson, D. H.; Savin, K. A.; Durst, G. L.; Hipskind, P. A. J. Med. Chem. 2004, 47, 224-232.
7. Veber, D. F; Johnson, S. R.; Cheng, H. Y; Smith, B. R.; Ward, K. W; Kopple, K. D. J. Med. Chem. 2002, 45, 2615-2623.
8. Smith, P. A.; Sorich, M. J.; Low, L. S. C.; McKinnon, R. A.; Miners, J. O. J. Mol. Graph. Model. 2004, 22, 507-517.
9. Comer, J. E.; Tam, K. Y Lipophilicity Profiles: Theory and Measurement. In Pharmacokinetic Optimization in Drug Research; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds.; Wiley-VCH: Zürich, 2001, pp 275-304.
10. Walther, B.; Vis, P; Taylor, A. Lipophilicity of Metabolites and its Role in Biotransformation. In Lipophilicity in Drug Action and Toxicology, Pliska, V, Testa, B., Van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996, pp 253-261.
11. Testa, B.; Cruciani, G. Structure-Metabolism Relations, and the Challenge of Predicting Biotransformation. In Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical and Computational Chemistry; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds.; Wiley-Verlag Helvetica Chimica Acta: Zürich, 2001, pp 65-84.
12. Testa, B. Drug Metabolism. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Wolff, M. E., Ed.; Wiley: New York, 1995; Vol. 1, pp 129-180.
13. Bouchard, G.; Carrupt, P. A.; Testa, B.; Gobry, V; Girault, H. H. Chem. Eur. J. 2002, 8, 3478-3484.
14. Avdeef, A. Assessment of Distribution-pH Profiles. In Lipophilicity in Drug Action and ; Pliska, V, Testa, B., Van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996, pp 109-139.
15. Caron, G. ; Reymond, F; Carrupt, P A. ; Girault, H. H. ; Testa, B. PSTT 1999, 2, 327-335.
16. Reymond, F; Gobry, V; Bouchard, G. ; Girault, H. H. Electrochemical Aspects of Drug Partitioning. In Pharmacokinetic Optimization in Drug Research; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds. ; Verlag Helvetica Chimica Acta: Zürich, 2001, pp 327-349.
17. Caron, G. ; Ermondi, G. Mini Rev. Medicinal Ghem. 2003, 3, 821-830.
18. Pagliara, A.; Reist, M.; Geinoz, S.; Carrupt, P. A.; Testa, B. J. Pharm. Pharmacol. 1999, 51, 1339-1357.
19. Young, R. C.; Mitchell, R. C.; Brown, T H.; Ganellin, C. R.; Griffiths, R.; Jones, M.; Rana, K. K.; Saunders, D.; Smith, I. R.; Sore, N. E. et al. J. Med. Ghem. 1988, 31, 656-671.
20. Chadha, H. S.; Abraham, M. H.; Mitchell, R. C. Bioorg. Med. Ghem. Lett. 1994, 4, 2511-2516.
21. Ashwood, V A.; Field, M. J.; Horwell, D. C.; Julien-Larose, C.; Lewthwaite, R. A.; McCleary, S.; Pritchard, M. C.; Raphy, J.; Singh, L. J. Med. Ghem. 2001, 44, 2276-2285.
22. Caron, G.; Ermondi, G. J. Med. Ghem. 2005, 48, 3269-3279.
23. Avdeef, A.; Kearney, D. L.; Brown, J. A.; Chemotti, A. R., Jr. Anal. Ghem. 1982, 54, 2322-2326.
24. Scherrer, R. A. The Treatment of Ionizable Compounds in QSAR Studies with Special Consideration to Ion [Pair] Partitioning. In Pesticide Synthesis Through Rational Approaches; Magee, P S., Kohn, G. K., Menn, G. G., Eds.; American Chemical Society: Washington, DC, 1984, pp 225-246.
25. a Values and the Lipophilicity of Ampholites and Ion Pairs. In Pharmacokinetic Optimization in Drug Research; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds.; Wiley-VCH: Zürich, 2001, pp 351-381.
26. Scherrer, R. A. Automated Titrations in KCl/Water-Saturated Octanol. In Pharmacokinetic Profiling in Drug Research, Biological, Physicochemical and Computational Strategies; Testa, B., Kraemer, S., Wunderli-Allenspach, H., Folkers, G., Eds.; Verlag Helvetica Chimica Acta: Zürich, 2004 (Presentation A35 included on CD).
27. Pagliara, A.; Khamis, E.; Trinh, A.; Carrupt, P. A.; Tsai, R. S.; Testa, B. J. Liq. Ghromatogr. 1995, 18, 1721-1745.
28. Steyaert, G.; Lisa, G.; Gaillard, P.; Boss, G.; Reymond, F; Girault, H. H.; Carrupt, P. A.; Testa, B. J. Ghem. Soc. Faraday Trans. 1997, 93, 401-406.
29. Pagliara, A.; Caron, G.; Lisa, G.; Fan, W; Gaillard, P.; Carrupt, P. A.; Testa, B.; Abraham, M. H. J. Ghem. Soc. Perkin Trans. 1997, 2, 2639-2643.
30. Maitland, G. C.; Rigby, M.; Smith, E. B.; Wakeham, W A. Intermolecular Forces, 2nd ed.; Breslow, R.; Goodenough, J. B.; Halpern, J.; Rowlinson, J. S., Eds.; International Series of Monographs on Chemistry; Oxford University Press: New York, 1987, pp. 1-88.
31. Blokzijl, W; Engberts, J. B. F N. Angew. Ghem. Int. Edit. 1993, 32, 1545-1579.
32. Gohlke, H.; Klebe, G. Angew. Ghem. Int. Edit. 2002, 41, 2645-2676.
33. Chandler, D. Nature 2002, 417, 491.
34. Sijbren, O.; Engberts, J. B. F N. Org. Biomol. Ghem. 2003, 1, 2820.
35. Van de Waterbeemd, H.; Testa, B. The Parametrization of Lipophilicity and Other Structural Properties in Drug Design. In Advances in Drug Research; Testa, B., Ed.; Academic Press: London, 1987; Vol. 16, pp 87-227.
36. Testa, B.; Carrupt, P A.; Gaillard, P; Tsai, R. S. Intramolecular Interactions Encoded in Lipophilicity: Their Nature and Significance. In Lipophilicity in Drug Action and Toxicology; Pliska, V, Testa, B., Van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996, Chapter 4, pp 49-71
37. Testa, B.; Seiler, P. Arzneimittel-Forsch 1981, 31, 1053-1058.
38. Van de Waterbeemd, H.; Carter, R. E.; Grassy, G.; Kubinyi, H.; Martin, Y C.; Tute, M. S.; Willett, P. Pure Appl. Ghem. 1997, 69, 1137-1152.
39. Austin, R. P.; Barton, P; Davis, A. M.; Manners, C. N.; Stansfield, M. C. J. Pharm. Sei. 1998, 87, 599-607.
40. Abraham, M. H.; Chadha, H. S. Application of a Solvation Equation to Drug Transport Properties. In Lipophilicity in Drug Action and Toxicology'; Pliska, V, Testa, B., Van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996, pp 311-337.
41. El Tayar, N.; Tsai, R. S.; Testa, B.; Carrupt, P. A.; Leo, A. J. Pharm. Sei. 1991, 80, 590-598.
42. Abraham, M. H.; Zhao, Y H. J. Org. Ghem. 2004, 69, 4677-4685.
43. Abraham, M. H.; Zhao, Y H. J. Org. Ghem. 2005, 70, 2633-2640.
44. Testa, B. Med. Ghem. Res. 1997, 7, 340-365.
45. Plemper van Balen, G.;a Marca Martinet, C.; Caron, G.; Bouchard, G.; Reist, M.; Carrupt, P. A.; Fruttero, R.; Gasco, A.; Testa, B. Med. Res. Rev. 2004, 24, 299-324.
46. Nasal, A.; Siluk, D.; Kaliszan, R. Gurr. Med. Ghem. 2003, 10, 381-426.
47. Lombardo, F; Shalaeva, M. Y; Tupper, K. A.; Gao, F; Abraham, M. H. J. Med. Ghem. 2000, 43, 2922-2928.
48. Lombardo, F; Shalaeva, M. Y; Tupper, K. A.; Gao, F J. Med. Ghem. 2001, 44, 2490-2497.
49. Yamagami, C. Recent Advances in Reversed-Phase HPLC Techniques to Determine Lipophilicity. In Pharmacokinetic Optimization in Drug Research; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds.; Wiley-VCH: Zurich, 2001, pp 383-400.
50. Van de Waterbeemd, H.; Kansy, M.; Wagner, B.; Fischer, H. Lipophilicity Measurement by Reversed-Phase High Performance Liquid Chromatography. In Lipophilicity in Drug Action and Toxicology; Pliska, V, Testa, B., Van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996, pp 73-87.
51. Kansy, M.; Fischer, H.; Van de Waterbeemd, H. Gorrelations Between Log P and Reverse Phase HPLG logkw-Values: Effect of Gharge and Gonformation'; Sanz, F; Giraldo, J.; Manaut, F, Eds.; Prous Science: Barcelona, 1995, pp 45-48.
52. Valko, K.; Snyder, L. R.; Glachj, J. L. J. Ghromatogr. A 1993, 656, 501-520.
53. Barbato, F; Caliendo, G.; La Rotonda, M. I.; Morrica, P.; Silipo, C.; Vittoria, A. Farmaco 1990, 45, 647-663.
54. Maran, U.; Karelson, M.; Katritzky, A. R. Quant. Struct.-Act. Rel. 1999, 18, 3-10.
55. Schop, H.; Wiese, M.; Cordes, H. P.; Seydel, J. K. Eur. J. Med. Ghem. 2000, 35, 619-634.
56. Collander, R. Acta Ghem. Scand. 1950, 4, 1085.
57. Collander, R. Acta Ghem. Scand. 1951, 5, 774.
58. Comer, J. E. High-Throughput Measurement of log D and pKa. In Drug Bioavailability'; Van de Waterbeemd, H., Lennernaes, H., Artursson, P, Eds.; Wiley-VCH: Weinheim, 2003, pp 21-45.
59. Wohnsland, F; Faller, B. J. Med. Ghem. 2001, 44, 923-930.
60. Box, K. J.; Comer, J. E.; Huque, F Correlations between PAMPA Permeability and log P. In Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical and Gomputational Strategies; Testa, B., Kraemer, S., Wunderli-Allenspach, H., Folkers, G., Eds.; Verlag Helvetica Chimica Acta: Zuürich, 2005, pp 243-257.
61. Liu, X.; Bouchard, G.; Müller, N.; Galland, A.; Girault, H. H.; Testa, B.; Carrupt, P. A. Helv. Ghim. Acta 2003, 86, 3533-3547.
62. Herbette, L.; Rhodes, D. G.; Preston Mason, R. Drug Design Deliv. 1991, 7, 75-118.
63. Caron, G.; Ermondi, G. New Insights into the Lipophilicity of Ionized Species. In Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical and Gomputational Strategies; Testa, B., Kraemer, S., Wunderli-Allenspach, H., Folkers, G., Eds.; Verlag Helvetica Chimica Acta: Zürich, 2005, pp 165-185.
64. Taillardat-Bertschinger, A.; Carrupt, P A.; Testa, B. Eur. J. Pharm. Sei. 2002, 15, 225-234.
65. Abraham, M. H.; Chadha, H. S.; Dixon, J. P.; Rafols, C.; Treiner, C. J. Chem. Soc., Perkin Trans. 1995, 2, 887-894.
66. Abraham, M. H.; Chadha, H. S.; Dixon, J. P.; Rafols, C.; Treiner, C. J. Chem. Säe., Perkin Trans. 1997, 2, 19-24.
67. Escuder-Gilabert, L.; Sagrado, S.; Villaneuva-Camanas, R. M.; Medina-Hernandez, M. J. Anal. Chem. 1998, 70, 28-34.
68. Escuder-Gilabert, L.; Sanchis-Mallols, J. M.; Sagrado, S.; Medina-Hernandez, M. J.; Villaneuva-Camanas, R. M. J. Chromatogr. A 1998, 823, 549-559.
69. Khaledi, M. G.; Breyer, E. D. Anal. Chem. 1989, 61, 1040-1047.
70. Ishihama, Y; Oda, Y; Uchikawa, K.; Asakawa, N. Chem. Pharm. Bull. 1994, 42, 1525-1527.
71. Van de Waterbeemd, H.; Kansy, M.; Wagner, B.; Fischer, H. Lipophilicity Measurement by Reversed-Phase High Performance Liquid Chromatography. In Lipophilieity in Drug Action and Toxicology'; Pliska, V, Testa, B., Van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996, pp 73-87.
72. Donovan, S. F; Pescatore, M. C. J. Chromatogr. A 2002, 952, 47-61.
73. Taillardat-Bertschinger, A.; Carrupt, P. A.; Barbato, F; Testa, B. J. Med. Chem. 2003, 46, 655-665.
74. Taillardat-Bertschinger, A.; a Marca Martinet, C.; Carrupt, P A.; Reist, M.; Caron, G.; Fruttero, R.; Testa, B. Pharm. Res. 2001, 19, 729-737.
75. Yang, C. Y; Cai, S. J.; Liu, H.; Pidgeon, C. Adv. Drug Deliv. Rev. 1996, 23, 229-256.
76. Liu, H.; Ong, S.; Glunz, L.; Pidgeon, C. Anal. Chem. 1995, 67, 3550-3557.
77. Barbato, F; di Martino, G.; Grumetto, L.; La Rotonda, M. I. Eur. J. Pharm. Sei. 2004, 22, 261-269.
78. Amato, M.; Barbato, F; Morrica, P.; Quaglia, F; La Rotonda, M. I. Helv. Chim. Acta 2000, 83, 2836-2847.
79. Taillardat-Bertschinger, A.; Barbato, F; Quercia, M. T; Carrupt, P. A.; Reist, M.; La Rotonda, M. I.; Testa, B. Helv. Chim. Acta 2002, 85, 519-532.
80. Valko, K.; My Du, C.; Bevan, C.; Reynolds, D.; Abraham, M. H. J. Pharm. Sei. 2000, 89, 1085-1095.
81. Alifrangis, L. H.; Christensen, I. T; Berglund, A.; Sandberg, M.; Hovgaard, L.; Frokjaer, S. J. Med. Chem. 2000, 43, 103-113.
82. Ong, S.; Liu, H.; Qiu, X.; Bhat, G.; Pidgeon, C. Anal. Chem. 1995, 67, 755-762.
83. Stewart, B. H.; Chan, O. H. J. Pharm. Sei. 1998, 87, 1471-1478.
84. Ducarme, A.; Neuwels, M.; Goldstein, S.; Massingham, R. Eur. J. Med. Chem. 1998, 33, 215-223.
85. Barbato, F; La Rotonda, M. I.; Quaglia, F Eur. J. Med. Chem. 1996, 31, 311-318.
86. Barbato, F; La Rotonda, M. I.; Quaglia, F J. Pharm. Sei. 1997, 86, 225-229.
87. Osterberg, T; Svensson, M.; Lundhal, P. Eur. J. Pharm. Sei. 2001, 12, 427-439.
88. Loidl-Stahlhofen, A.; Eckert, A.; Hartmann, T; Schöttner, M. J. Pharm. Sei. 2001, 90, 599-606.
89. Loidl-Stahlhofen, A.; Hartmann, T.; Schöttner, M.; Röhring, C.; Brodowsky, H.; Schmitt, J.; Keldenisch, J. Pharm. Res. 2001, 18, 1782-1788.
90. Dearden, J. C.; Bresnen, G. M. Quant. Struct.-Act. Rel. 1988, 7, 133-144.
91. Kratochwil, N. A.; Huber, W; Muller, F; Kansy, M.; Gerber, P. R. Bioehem. Pharmacol. 2002, 64, 1355-1374.
92. Zhu, C.; Jiang, L.; Chen, T.-M.; Hwang, K.-K. Eur. J. Med. Chem. 2002, 37, 399-407.
93. Valko, K. Separation Methods in Drug Synthesis and Purification. In Handbook of Analytical Separations'; Smith, R. M., Ed.; Elsevier: Amsterdam, 2000, pp 539-542.
94. Clarke, F. H.; Cahoon, N. M. J. Pharm. Sei 1996, 85, 178-183.
95. Takacs-Novak, K.; Avdeef, A. J. Pharm. Biomed. Anal. 1996, 14, 1405-1413.
96. Avdeef, A.; Barrett, A.; Shaw, P. N.; Knaggs, R. D.; Davis, S. S. J. Med. Chem. 1996, 39, 4377-4381.
97. Slater, B.; McCormack, A.; Avdeef, A.; Comer, J. E. J. Pharm. Sei. 1994, 83, 1280-1283.
98. Caron, G.; Ermondi, G.; Damiano, A.; Novaroli, L.; Tsinman, O.; Ruell, J. A.; Avdeef, A. Bioorg. Med. Chem. 2004, 12, 6107-6118.
99. Bouchard, G.; Pagliara, A.; Plemper van Balen, G.; Carrupt, P. A.; Testa, B.; Gobry, V; Girault, H. H.; Caron, G.; Ermondi, G.; Fruttero, R. Helv. Chim. Acta 2001, 84, 375-387.
100. Plemper van Balen, G.; Carrupt, P A.; Morin, D.; Tillement, J. P.; Le Ridant, A.; Testa, B. Biochem. Pharmacol. 2002, 63, 1691-1697.
101. Avdeef, A.; Box, K. J.; Comer, J. E. A.; Hibbert, C.; Tam, K. Y Pharm. Res. 1998, 15, 209-215.
102. Plemper van Balen, G.; Caron, G.; Ermondi, G.; Pagliara, A.; Grandi, T; Bouchard, G.; Fruttero, R.; Carrupt, P. A.; Testa, B. Pharm. Res. 2001, 18, 694-701.
103. Fruttero, R.; Caron, G.; Fornatto, E.; Boschi, D.; Ermondi, G.; Gasco, A.; Carrupt, P. A.; Testa, B. Pharm. Res. 1998, 15, 1407-1413.
104. Caron, G.; Ermondi, G.; Boschi, D.; Carrupt, P. A.; Fruttero, R.; Testa, B.; Gasco, A. Helv. Chim. Acta 1999, 82, 1630-1639.
105. Caron, G.; Gaillard, P; Carrupt, P. A.; Testa, B. Helv. Chim. Acta 1997, 80, 449-462.
106. Ulmeanu, S. M.; Jensen, H.; Bouchard, G.; Carrupt, P. A.; Girault, H. H. Pharm. Res. 2003, 20, 1317-1322.
107. Liu, X.; Bouchard, G.; Girault, H. H.; Testa, B.; Carrupt, P. A. Anal. Chem. 2003, 75, 7036-7039.
108. Bouchard, G.; Pagliara, A.; Carrupt, P. A.; Testa, B.; Gobry, V; Girault, H. H. Pharm. Res. 2002, 19, 1150-1159.
109. Gobry, V; Bouchard, G.; Carrupt, P. A.; Testa, B.; Girault, H. H. Helv. Chim. Acta 2000, 83, 1465-1474.
110. Chopineaux-Courtois, V; Reymond, F; Bouchard, G.; Carrupt, P. A.; Testa, B.; Girault, H. H. JACS 1999, 121, 1743-1747.
111. Caron, G.; Steyaert, G.; Pagliara, A.; Reymond, F; Crivori, P; Gaillard, P; Carrupt, P. A.; Avdeef, A.; Comer, J. E.; Box, K. J. et al. Helv. Chim. Acta 1999, 82, 1211-1222.
112. Reymond, F; Brevet, P. F; Carrupt, P. A.; Girault, H. H. J. Electroanal Chem. 1997, 424, 121-139.
113. Faller, B.; Grimm, H. P; Loeuillet-Ritzler, F; Arnold, S.; Briand, S. J. Med. Chem. 2005, 48, 2571-2576.
114. Krämer, S. D. Liposome/Water Partitioning: Theory, Techniques and Applications. In Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical and Computational Strategies'; Testa, B., Van de Waterbeemd, H., Folkers, G., Guy, R. H., Eds.; Wiley-Verlag Helvetica Chimica Acta: Zürich, 2001, pp 401-428.
115. Galland, A.; Bouchard, G.; Caron, G.; Plemper van Balen, G.; a Marca Martinet, C.; Geinoz, S.; Rey, S.; Ermondi, G.; Vacondio, F; Mor, M. et al. Chimia 2002, 56, 373.
116. Avdeef, A. Quant. Struct.-Act. Rel. 1992, 11, 510-517.
117. Avdeef, A. J. Pharm. Sei. 1993, 82, 183-190.
118. Avdeef, A. Absorption and Drug Development. Solubility, Permeability, and Charge State; Wiley: New York, 2003.
119. Kubinyi, H. QSAR: Hansch Analysis and Related Approaches; VCH: Weinheim, 1993.
120. Escher, B. I.; Schwarzenbach, R. P. Environ. Sci. Technol. 1996, 30, 260-270.
121. Westheimer, F. W. Science 1987, 235, 1173-1178.
122. Abraham, M. H.; Takacs-Novak, K.; Mitchell, R. C. J. Pharm. Sei. 1997, 86, 310-315.
123. Gobry, V; Ulmeanu, S. M.; Reymond, F; Bouchard, G.; Carrupt, P. A.; Testa, B.; Girault, H. H. JACS 2001, 123, 10684-10690.
124. Meyer, J. D.; Manning, M. C. Pharm. Res. 1998, 15, 188-193.
125. Lengsfeld, C. S.; Pitera, D.; Manning, M. C.; Randolph, T W Pharm. Res. 2002, 19, 1572-1576.
126. Feng, L.; De Dille, A.; Jameson, V J.; Smith, L.; Dernell, W S.; Manning, M. C. Cancer Chemother. Pharm. 2004, 54, 441-448.
127. Falk, R.; Randolph, T W; Meyer, J. D.; Kelly, R. M.; Manning, M. C. J. Control. Release 1997, 44, 77-85.
128. Zhou, H.; Lengsfeld, G.; Claffey, D. J.; Ruth, J. A.; Hybertson, B.; Randolph, T W; Manning, M. C. J. Pharm. Sei 2002, 91, 1502-1511.
129. Austin, R. P.; Davis, A. M.; Manners, C. N. J. Pharm. Sei. 1995, 84, 1180-1183.
130. Büuerle, H.-D.; Seelig, J. Biochemistry 1991, 30, 7203-7211.
131. Preston Mason, R.; Campbell, S. F; Wang, S.-D.; Herbette, L. Mol. Pharmacol. 1989, 36, 634-640.
132. Preston Mason, R. Biochem. Pharmacol. 1993, 45, 2173-2183.
133. Austin, R. P; Barton, P; Bonnert, R. V; Brown, R. C.; Cage, P. A.; Cheshire, D. R.; Davis, A. M.; Dougall, I. G.; Ince, F; Pairaudeau, G. et al. J. Med. Chem. 2003, 46, 3210-3220.
134. Krüamer, S. D.; Braun, A.; Jakits-Deiser, C.; Wunderli-Allenspach, H. Pharm. Res. 1998, 15, 739-744.
135. Marenchino, M.; Alpstüg-Wohrle, A.; Christen, B.; Wunderli-Allenspach, H.; Krämer, S. D. Eur. J. Pharm. Sei. 2004, 21, 313-321.
136. Kaliszan, R.; Nasal, A.; Bucinski, A. Eur. J. Med. Chem. 1994, 29, 163-170.
137. Taillardat-Bertschinger, A.; Carrupt, P. A.; Barbato, F; Testa, B. J. Med. Chem. 2003, 46, 655-665.
138. Ottiger, C.; Wunderli-Allenspach, H. Pharm. Res. 1999, 16, 643-650.
139. Pagliara, A.; Carrupt, P. A.; Caron, G.; Gaillard, P; Testa, B. Chem. Rev. 1997, 97, 3385-3400.
140. Tsai, R. S.; Carrupt, P. A.; Testa, B.; Gaillard, P.; El Tayar, N.; Hoegberg, T J. Med. Chem. 1993, 36, 196-204.
141. Colaizzi, J. L.; Klink, P R. J. Pharm. Sei. 1969, 58, 1184-1189.
142. Pagliara, A.; Testa, B.; Carrupt, P A.; Jolliet, P.; Morin, C.; Morin, D.; Urien, S.; Tillement, J. P.; Rihoux, J. P. J. Med. Chem. 1998, 41, 853-863.
143. Avdeef, A. Sirius Technical Application Notes 2; Sirius Analytical Instruments: East Sussex, 1995, pp 12-16a.
144. Tsai, R. S.; Carrupt, P. A.; El Tayar, N.; Testa, B.; Giroud, Y.; Andrade, P; Brée, F; Tillement, J. P. Helv. Chim. Acta 1993, 76, 842-854.
145. Caron, G.; Pagliara, A.; Carrupt, P A.; Gaillard, P; Testa, B. Helv. Chim. Acta 1996, 79, 1683-1685.
146. Scherrer, R. A.; Howard, S. M. J. Med. Chem. 1977, 20, 53-58.
147. Scherrer, R. A.; Donovan, S. F 29th Species-Specific LogD in Drug Design andADMET ; 29th National Medicinal Chemistry Symposium, Madison, WI, 27 June-1 July 2004, Abst. A70.
148. Lombardo, F; Obach, R.; Shalaeva, M. Y.; Gao, F J. Med. Chem. 2004, 47, 1242-1250.
149. Thomae, A. V; Wunderli-Allenspach, H.; Krümer, S. D. Biophys. J. 2005, 89, 1802-1811.
150. Tetko, I. V; Poda, G. I. J. Med. Chem. 2004, 47, 5601-5604.
151. Berthod, A.; Carda-Broch, S.; Garcia-Alvarez-Coque, M. C. Anal. Chem. 1999, 71, 879-888.
152. Fujii, T; Nishida, H.; Abiru, Y.; Yamamoto, M.; Kise, M. Chem. Pharm. Bull. 1995, 43, 1872-1877.
153. Avdeef, A. Sirius Technical Application Notes 1; Sirius Analytical Instruments: East Sussex, 1994, pp 146-147.